Mashup Score:2
Wall Street JournalBionic Pancreas Shown to Manage Blood-Sugar Levels for Type 1 Diabetics - 10 hours
Mashup Score:2
Articles from: Wall Street Journal
Mashup Score:105
Wall Street JournalOpinion | Should Medicare Decide If You Can Get an Alzheimer’s Drug? - 10 hours
Mashup Score:105
The agency that oversees the program is operating outside its legal lane to deny coverage of an innovative new...
-
Given the positive news today, on a drug that treats Alzheimer's through a novel mechanism; will Medicare reconsider the framework of its decision last year to effectively rebuff this category of drugs? Re-upping my op ed on that issue from January 2022. https://t.co/l9bZfvPi1H - view on twitter
Mashup Score:1
Wall Street JournalAlzheimer’s Drug Slows Disease Progression in Trial - 13 hours
Mashup Score:1
Eisai and Biogen said their experimental Alzheimer’s drug significantly slowed progression of the memory-robbing disease in a large study, bolstering the drug’s prospects of...
-
An Alzheimer’s drug significantly slowed Alzheimer’s disease in a new study, bolstering the drug’s prospects ahead of an FDA approval decision next year https://t.co/tQQqFBJN9G https://t.co/tQQqFBJN9G - view on twitter
The new bivalent vaccine might be the first step in developing annual Covid shots, which could follow a similar process to the one used...
-
WATCH: Covid vaccines could mirror the flu shot process. Here’s what that means: https://t.co/3wm6eoS2zj - view on twitter
Mashup Score:2
Wall Street JournalStarting School Before 8 a.m. Can Be Harmful to Teens, Sleep Scientists Say - 15 hours
Mashup Score:2
One possible way to help teenagers facing rising mental health issues: start school...
-
Starting school at 7:30 a.m. isn't good for teens, psychologists say https://t.co/rX3BZQxRTv - view on twitter
The measures would hit nearly $7 billion of Russian exports and ban the sale to Russia of new technologies, while the bloc will start...
-
RT @AtsukoHigashino: WSJも出ました。内容的には上記とほぼ一緒。これからEU内での協議が進められる見通しです。 https://t.co/rUdLWpfAtq - view on twitter
Eisai and Biogen said their experimental Alzheimer’s drug significantly slowed progression of the memory-robbing disease in a large study, bolstering the drug’s prospects of...
-
An Alzheimer’s drug significantly slowed Alzheimer’s disease in a new study, bolstering the drug’s prospects ahead of an FDA approval decision next year https://t.co/DTaXkhe7gu - view on twitter
Mashup Score:6
Wall Street JournalWhat Science Says About How to Eat Better - 19 hours
Mashup Score:6
Many of the strategies that you think will work don’t. Here are the surprising things that...
-
These are the science-backed strategies that will help you make healthier food choices https://t.co/ke8OlPxBOO - view on twitter
Mashup Score:2
Wall Street JournalBiogen Agrees to Pay $900 Million Over Alleged Improper Physician Payments - 22 hours
Mashup Score:2
The pharmaceutical company allegedly used speaking and consulting fees to persuade doctors to prescribe its multiple sclerosis...
-
Biogen Inc. agreed to pay $900 million to settle allegations that it paid kickbacks to doctors to induce them to prescribe the company’s drugs, the Justice Department said https://t.co/dHnufOyO1u - view on twitter
Mashup Score:20
Wall Street JournalAlzheimer’s Drug Slows Disease Progression in Trial - 1 day
Mashup Score:20
Eisai and Biogen said their experimental Alzheimer’s drug significantly slowed progression of the memory-robbing disease in a large study, bolstering the drug’s prospects of...
-
Positive Alzheimers/amyloid news. Hope it stands up to further evaluation. https://t.co/mPUhCZDnge - view on twitter
Automated iLet device from Beta Bionics manages blood-sugar levels with less user...
A bionic pancreas helped people with Type 1 diabetes manage blood-sugar levels more effectively than other treatment methods, a new study shows https://t.co/l22Jg8QohY - view on twitter